UBS O'Connor’s Kite Pharma, Inc. KITE Stock Holding History

UBS O'Connor’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-334,153	Closed	-$60.1M	–	430
2017 Q3	$60.1M	Buy	+334,153	New	+$46.6M	0.87%	23
2016 Q1	–	Sell	-8,000	Closed	-$492K	–	565
2015 Q4	$492K	Buy	+8,000	New	+$563K	﹤0.01%	388
2015 Q1	–	Sell	-18,445	Closed	-$1.06M	–	921
2014 Q4	$1.06M	Buy	+18,445	New	+$777K	0.02%	351

UBS O'Connor's KITE Position: Q4 2017 in Review

UBS O'Connor sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 334,153 shares — an estimated $60.1M sold.

UBS O'Connor first reported a position in KITE in Q4 2014 and held it in 3 quarters. The position peaked at $60.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

UBS O'Connor reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
UBS O'Connor sold 334,153 Kite Pharma, Inc. shares in Q4 2017, an estimated $60.1M.
UBS O'Connor first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 3 quarters.
UBS O'Connor's Kite Pharma, Inc. position peaked at $60.1M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on UBS O'Connor's 13F filing for Q4 2017, filed 14 Feb 2018.